These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27471003)

  • 21. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells.
    Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F
    J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression.
    Jung D; Kullak-Ublick GA
    Hepatology; 2003 Mar; 37(3):622-31. PubMed ID: 12601360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FXR controls CHOP expression in steatohepatitis.
    Fuchs CD; Claudel T; Scharnagl H; Stojakovic T; Trauner M
    FEBS Lett; 2017 Oct; 591(20):3360-3368. PubMed ID: 28895119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis.
    Ho PP; Steinman L
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1600-5. PubMed ID: 26811456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages.
    Cao S; Meng X; Li Y; Sun L; Jiang L; Xuan H; Chen X
    Front Immunol; 2021; 12():632864. PubMed ID: 33968024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.
    Lee J; Padhye A; Sharma A; Song G; Miao J; Mo YY; Wang L; Kemper JK
    J Biol Chem; 2010 Apr; 285(17):12604-11. PubMed ID: 20185821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
    Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
    J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
    Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
    FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional Regulation of Human UDP-Glucuronosyltransferase 2B10 by Farnesoid X Receptor in Human Hepatoma HepG2 Cells.
    Lu D; Wang S; Xie Q; Guo L; Wu B
    Mol Pharm; 2017 Sep; 14(9):2899-2907. PubMed ID: 28267333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Farnesoid X receptor represses hepatic lipase gene expression.
    Sirvent A; Verhoeven AJ; Jansen H; Kosykh V; Darteil RJ; Hum DW; Fruchart JC; Staels B
    J Lipid Res; 2004 Nov; 45(11):2110-5. PubMed ID: 15342685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III.
    Ghosh Laskar M; Eriksson M; Rudling M; Angelin B
    J Intern Med; 2017 Jun; 281(6):575-585. PubMed ID: 28145001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
    Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
    J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the Farnesoid X Receptor (FXR) Suppresses Linoleic Acid-Induced Inflammation in the Large Yellow Croaker (Larimichthys crocea).
    Du J; Chen Q; Li Y; Xiang X; Xu W; Mai K; Ai Q
    J Nutr; 2020 Sep; 150(9):2469-2477. PubMed ID: 32614453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
    Zhang HM; Wang X; Wu ZH; Liu HL; Chen W; Zhang ZZ; Chen D; Zeng TS
    Mol Med Rep; 2016 Mar; 13(3):2135-42. PubMed ID: 26782298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
    Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
    Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
    Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.